Across emergency care, outpatient screening, critical care monitoring, and primary care settings, fast, accurate, quantitative in vitro diagnostics are the foundation of confident clinical decision-making. Backed by advanced technology, a comprehensive...

Ever wondered how doctors get those spot-on results for blood-related health checks? Behind the scenes, there's a game-changer: the Laffinite II HPLC Hemoglobin Analyzer from AEHEALTH! Designed to make diagnostic testing smoother, more accurate, and pati...

As health remains a universal priority, the in vitro diagnostic (IVD) industry acts as healthcare’s "frontline sentinel." Aehealth, a leading IVD manufacturer rooted in Shenzhen—with global hubs in Hong Kong and Manchester—has emerged as a ...

The global number of patients with thyroid dysfunction continues to rise. According to 2024 epidemiological data, over 40% of patients with thyroid disease already show significant functional abnormalities at initial diagnosis. Status of High-Risk Group...

#ImmunofluorescenceAssay #ArthritisScreening #AntiCCPTesting #RheumatoidFactor #InflammationMarkers #POCTInnovation The Global Arthritis Burden: Critical Diagnostic GapsWHO 2025 Data Insights Of nearly 500 million arthritis patients globally, over 60% d...

The Gatekeeper of Heart Health: Clinical Value of the CK-MB/CTnI/MYO Panel As World Heart Day approaches, early diagnosis and intervention for heart health are once again a global focus. Creatine Kinase MB (CK-MB), Cardiac Troponin I (CTnI), and Myoglobin (...

PRL and AMH: Clinical Significance and Diagnostic Challenges Prolactin (PRL) and Anti-Müllerian Hormone (AMH) are critical indicators for assessing reproductive endocrine health and fertility. Abnormal elevation of PRL can lead to menstrual disorders, ...

#ImmunofluorescenceAssay #LamunoXAnalyzer #AnemiaScreening #VB12Testing #FerritinQuantification #POCTInnovation Global Anemia Crisis: Critical Gaps WHO 2025 Data Insights Diff - 570M anemia patients misdiagnosed without VB12/Ferritin testing - Worl...